1 position(s) for US Immunology Field Medical & Medical Evidence Generation (MEG)

Fellowship Position Office Location: Lawrenceville, NJ 08648 

POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships and Bristol Myers Squibb Program emphasis is in US Immunology Field Medical & Medical Evidence Generation (MEG)

The Immunology Field Medical & Medical Evidence Generation (MEG) position is a two-year fellowship that will provide a unique opportunity to gain expertise in multiple dimensions of the medical affairs function in the immunology space. During their first year, the fellow will join the US Immunology Field Medical team and participate in key projects, critical to the success of new product/indication launches and currently approved products. The fellow will gain an appreciation for core Field Medical competencies spanning field training, operations, and thought leader (TL)/investigator engagement. In their second year, the fellow will join the MEG team and contribute to the development and implementation of the Integrated Evidence Plan (IEP) and interaction with the different modalities of evidence generation (investigator-sponsored studies, interventional and noninterventional company-sponsored trials, collaborative research, data mining and exploratory analysis among others). During the fellowship, the candidate is expected to participate in multiple important events including phase II and III study read-outs, design, implementation of Phase IIIb/IV studies, and preparation for global launch(es).

US IMMUNOLOGY FIELD MEDICAL

• Serve as an integral part of the Immunology Field Medical Strategy and Training team and key contributor for field medical planning, stakeholder communications, and launch/life-cycle management projects.
• Gain product and therapeutic expertise in Immunology as foundational knowledge to apply to various projects and activities.
• Collaborate with home office and field matrix teams to assist in the development of training initiatives and medical resources.
• Contribute on innovative tactics and/or platforms to elevate MSL development and productivity in the field.
• Participate in MSL trainings and assessments. Fellow will have the opportunity to accompany MSLs on field rides and virtual interactions to gain an understanding of diverse experiences with TLs and study investigators.

MEDICAL EVIDENCE GENERATION (MEG)

• Support the development, tracking and maintenance of the Integrated Evidence Plans (IEPs) that reflects asset strategy, market priorities and medical evidence generation support in partnership with the I&F Global Medical Disease Team and cross-functional teams including (but not limited to) Global Drug Development (GDD), Translational Development, Health Economics and Outcomes Research (HEOR), and others.
• Develop Areas of Interest (AOI) based on key open data questions (ODQ) identified in the IEP with market input in collaboration with the I&F Global Medical Disease Team
• Manage the scientific aspects of the ongoing I&F Investigator-sponsored Research (ISR) book of work and serve as the subject matter expert and interface with all key stakeholders across the matrix.
• Conduct regular book of work reviews in partnership with GDO with key medical and development stakeholders, under their remit. Identify studies at risk for failing to meet timelines and negotiated mitigation plans with key internal stakeholders and investigators.
• Assist in the reviews of concepts through RFP (Request For Proposals) process, as appropriate, including providing context for ongoing book of work, area of interest development, and upcoming data read-outs.

University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader. For more information and to apply, please visit our website: http://pharmafellows.rutgers.edu

Do not click the Apply Now button to the right. We do not pre-schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at http://pharmafellows.rutgers.edu

The RPIF program will be conducting initial interviews on a rolling basis virtually (video/teleconference) starting October 23rd. To apply, candidates MUST use the RPIF website (http://pharmafellows.rutgers.edu/how-to-apply/) to create a RPIF Candidate Account and upload the required application materials by the dates noted below. Remember that the application process is on a rolling basis, so earlier is better.  Please see our website for additional important recruitment information and dates. 

Once all interviews have been completed, Rutgers or the company will notify interviewed candidates of their position-specific candidacy status. 

Candidate Checklist:

1. Create an RPIF Candidate Account starting now.
2. Upload RPIF Application Materials to RPIF Candidate Account starting October 06, 2023. 
1. Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and upload your Letter of Intent and Curriculum Vitae (CV) by October 13, 2023.
2. Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1, 2023.
3. RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.

As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas.

Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law.

Other commitments can be found at the link below:

https://uhr.rutgers.edu/prospective-employees/the-ru-commitment

About Rutgers, the State University of New Jersey

The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large. The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.

Connections working at Rutgers, the State University of New Jersey